Merck to Ask FDA for Emergency Approval of Its New Antiviral Pill for COVID

0
367

[ad_1]

photo of coronavirus

The drug maker claims clinical trials of its new antiviral pill molnupiravir shows the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection with COVID-19.

[ad_2]